IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis

Changes in glycosylation are salient features of cancer cells. Here, we report on the diagnostic and therapeutic properties of IDK1, an antibody against tumour associated, hypoglycosylated bone sialoprotein (hypo‐BSP). The affinity of the rat monoclonal antibody IDK1 for hypo‐BSP, as determined by m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zepp, Michael, Kovacheva, Marineta, Altankhuyag, Munkhtsetseg, Westphal, Gabriela, Berger, Irina, Gather, Katharina S, Hilbig, Heidegard, Neuhaus, Jochen, Hänsch, Gertrud M, Armbruster, Franz P, Berger, Martin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783975/
https://www.ncbi.nlm.nih.gov/pubmed/29416877
http://dx.doi.org/10.1002/cjp2.88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783975/
https://www.ncbi.nlm.nih.gov/pubmed/29416877
http://dx.doi.org/10.1002/cjp2.88

Ejemplares similares